FDA.reportPublic FDA data

Ranexa 1000 MG 12 HR Extended Release Oral Tablet

RxCUI
860737
RxNorm name
Ranexa 1000 MG 12 HR Extended Release Oral Tablet
Display name
Ranexa 1000 MG 12 HR Extended Release Oral Tablet
Full name
Ranexa 1000 MG 12 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8d442b8c-97a8-40a9-8603-f9cd0542cedcRanexa 1000 MG 12HR Extended Release Oral Tablet [PSN] · 12 HR ranolazine 1000 MG Extended Release Oral Tablet [Ranexa] [SBD] · Ranexa 1000 MG 12 HR Extended Release Oral Tablet [SY]32These highlights do not include all the information needed to use Ranexa safely and effectively. See full prescribing information for Ranexa. Ranexa (ranolazine) extended-release tablets Initial U.S. Approval: 200620100426